Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Not applicableUnknownNCT05343611
What this trial is testing

Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People

Who this might be right for
DementiaDementia, MildDementia Moderate+4 more
Massimo Venturelli, PhD 102
Early research (Phase 1)Ended earlyNCT03179501
What this trial is testing

NP001, Alzheimer's Disease, and Blood Markers of Inflammation

Who this might be right for
Alzheimer Disease
Beau Nakamoto 4
Testing effectiveness (Phase 2)Ended earlyNCT05478031
What this trial is testing

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
reMYND 14
Large-scale testing (Phase 3)Looking for participantsNCT07066826
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD 720
Testing effectiveness (Phase 2)Study completedNCT01764243
What this trial is testing

Safety and Efficacy of MT-4666

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 450
Not applicableUnknownNCT05251649
What this trial is testing

Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chinese PLA General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00574132
What this trial is testing

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,331
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Testing effectiveness (Phase 2)Study completedNCT00876863
What this trial is testing

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 49
Testing effectiveness (Phase 2)Study completedNCT00112073
What this trial is testing

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 234
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Testing effectiveness (Phase 2)Study completedNCT00752232
What this trial is testing

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 40
Testing effectiveness (Phase 2)Ended earlyNCT06833281
What this trial is testing

Extension Study of Participants From SPG302-ALZ-101

Who this might be right for
Alzheimer's Disease
Spinogenix 12
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Not applicableStudy completedNCT02711683
What this trial is testing

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital Xi'an Jiaotong University 92
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Testing effectiveness (Phase 2)Study completedNCT04079803
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 64
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT00810147
What this trial is testing

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 209
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation